Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Horizon Discovery Group PLC    HZD   GB00BK8FL363

HORIZON DISCOVERY GROUP PLC (HZD)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
04/17/2018 04/18/2018 04/19/2018 04/20/2018 04/23/2018 Date
146(c) 149(c) 149(c) 148.5(c) 154.5 Last
181 352 304 450 47 732 1 808 585 48 350 Volume
+4.29% +2.05% 0.00% -0.34% +4.04% Change
More quotes
Financials (GBP)
Sales 2017 36,3 M
EBIT 2017 -7,35 M
Net income 2017 -8,80 M
Finance 2017 31,2 M
Yield 2017 -
Sales 2018 60,4 M
EBIT 2018 -0,89 M
Net income 2018 -1,30 M
Finance 2018 26,2 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 5,25x
EV / Sales2018 3,23x
Capitalization 221 M
More Financials
Company
Horizon Discovery Group Plc is a gene editing company that designs and engineers genetically-modified cells, applying them in research and clinical applications to advance human health.It serves pharmaceutical, biotechnology and diagnostic companies.The company was founded by Christopher John... 
More about the company
Surperformance© ratings of Horizon Discovery Group PL
Trading Rating : Investor Rating :
More Ratings
Latest news on HORIZON DISCOVERY GROUP PL
04/12HORIZON DISCOVERY : enters into partnership with Pirbright Institute to support ..
PU
04/06HORIZON DISCOVERY : Director/PDMR Shareholding
PU
03/29HORIZON DISCOVERY : Bioproduction Cell Line Used as Part of a Successful Drug IN..
AQ
03/21HORIZON DISCOVERY : ’s Bioproduction Cell Line Used as Part of a Successfu..
BU
03/05Horizon Discovery hosts Capital Markets Day today
GL
02/20HORIZON DISCOVERY GROUP PLC : Capital Markets Day Date Change to 5 March 2018
GL
02/20HORIZON DISCOVERY : Capital Markets Day Date Change to 5 March 2018
PU
02/20HORIZON DISCOVERY : Announces Leadership Changes
PU
02/12HORIZON DISCOVERY : Non-Exclusive License Agreement
PU
02/12Horizon Discovery Enters into License Agreement with US Immuno-Oncology Compa..
GL
More news
Sector news : Biotechnology & Medical Research - NEC
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
04/12Horizon Discovery : enters into partnership with Pirbright Institute to suppo.. 
04/06$HZD Discovery Group Plc 1 director bought: A director at Horizon Discovery .. 
03/21Horizon Discovery’s Bioproduction Cell Line Used as Part of a Successful Drug.. 
03/21Horizon Discovery’s Bioproduction Cell Line Used as Part of a Successful Drug.. 
03/21Horizon Discovery’s Bioproduction Cell Line Used as Part of a Successful Drug.. 
More tweets
Qtime:33
Chart HORIZON DISCOVERY GROUP PL
Duration : Period :
Horizon Discovery Group PL Technical Analysis Chart | HZD | GB00BK8FL363 | 4-Traders
Technical analysis trends HORIZON DISCOVERY GROUP PL
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 2,37  GBP
Spread / Average Target 59%
EPS Revisions
Managers
NameTitle
Richard John Vellacott CEO, CFO, Secretary & Executive Director
Ian David Gilham Executive Chairman
Jürgen Harter Global Head-IT & Informatics
Jonathan D. Moore Chief Scientific Officer
Jonathan Simon Milner Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
HORIZON DISCOVERY GROUP PLC-38.13%310
CELLTRION, INC.--.--%31 467
IQVIA HOLDINGS INC-0.64%20 258
LONZA GROUP-6.95%18 703
INCYTE CORPORATION-27.75%14 493
NEKTAR THERAPEUTICS44.36%13 873